Short-Course Rifampin and Pyrazinamide Compared with Isoniazid for Latent Tuberculosis Infection: A Cost-Effectiveness Analysis Based on a Multicenter Clinical Trial

Autor:	Snyder, David C., Bernardo, John
Zdroj:	Clinical Infectious Diseases, 2004 Feb 01. 38(3), 363-369.
Databáze:	JSTOR Journals
Externí odkaz:	https://www.jstor.org/stable/4462790 Zobrazit plný text záznamu